Medical Spa
Dysport is an injectable used to minimize the appearance of wrinkles and frown lines in the face by allowing the muscles in the face to relax. It is made using small amounts of botulinum toxin Type A and in some ways is similar to BOTOX.
However select premier practices such as Marina Plastic Surgery Associates in Marina Del Rey already have the product and are offering it to patients as a more cost effective alternative to BOTOX or Dysport ...
So successful was BOTOX that several competitors have emerged for treatment of wrinkles and lines: Dysport and now Xeomin scheduled to be available in the U ...
When we consult with our patients about non-surgical facial rejuvenation that will fit into their budgets we often first suggest neurotoxins such as BOTOX or Dysport ...
Dr Chapas suggests using the injectable Dysport to help minimize their look ...
BOTOX Dysport & Zeomin typically last 3 to 4 months the newest neuromodulator currently known as RT002 is undergoing FDA trials ...
As plastic surgeons across the nation gather in Boston this weekend for The Aesthetic Meeting hosted by The American Society for Aesthetic Plastic Surgery (ASAPS) many new plastic surgery techniques will be discussed as well as Practice Management and Online Marketing sessions
Dr Lori BrightmanDr Lori Brightman a Board Certified Dermatologist completed her residency training at Boston University /Tufts New England Medical Center combined program
The coalition wants to help patients make informed decisions states Dr Ioannis Glavas a board certified oculoplastic and facial cosmetic surgeon with offices in Boston and New York
Zeltiq Results of Dr Christopher ZacharyDeveloped at the Wellman Center for Photomedicine at Massachusetts General Hospital in Boston the CoolSculpting breakthrough is based on extensive scientific research that demonstrates that fat cells are more susceptible to extreme cold and are selectively painlessly and permanently destroyed
The science behind the Zeltiq Procedure is called Cryolipolysis which was developed by world-renowned dermatologists at Massachusetts General Hospital in Boston MA USA an affiliate of Harvard Medical School